{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:17:23Z","timestamp":1762521443258},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.eimc.2011.03.009","type":"journal-article","created":{"date-parts":[[2011,9,16]],"date-time":"2011-09-16T17:41:04Z","timestamp":1316194864000},"page":"631","source":"Crossref","is-referenced-by-count":3,"title":["Adenitis tuberculosa tras tratamiento con \u00e9xito de hepatitis C"],"prefix":"10.1016","volume":"29","author":[{"given":"Javier","family":"Velasco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2011.03.009_bib0005","doi-asserted-by":"crossref","unstructured":"National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002-June 10-12, 2002. Hepatology. 2002;36: Suppl 1:S3\u201320.","DOI":"10.1002\/hep.1840360703"},{"key":"10.1016\/j.eimc.2011.03.009_bib0010","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for inicial treatment of chronic hepatits C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.eimc.2011.03.009_bib0015","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2011.03.009_bib0020","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa040842","article-title":"Peginterferon a-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients","volume":"351","author":"Torriani","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2011.03.009_bib0025","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1177\/135965350601100814","article-title":"Outcome of chronic hepatitis C patients who required early termination of pegylated interferon-a plus ribavirin combination therapy","volume":"11","author":"Yu","year":"2006","journal-title":"Antivir Ther"},{"key":"10.1016\/j.eimc.2011.03.009_bib0030","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1086\/597503","article-title":"Tuberculosis complicating hepatitis C treatment in HIV-infected patients","volume":"48","author":"P\u00e9rez-El\u00edas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2011.03.009_bib0035","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/ncpgasthep1176","article-title":"Generalized peripheral lymphadenopathy in a patient treated for chronic HCV infection","volume":"5","author":"Ferrerira","year":"2008","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.eimc.2011.03.009_bib0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/00365540500263268","article-title":"Reactivation of severe, acute pulmonary tuberculosis during treatment with pegylated interferon-alpha and ribavirin for chronic HCV hepatitis","volume":"38","author":"Sabbatani","year":"2006","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.eimc.2011.03.009_bib0045","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.revmed.2009.11.017","article-title":"Reactivation of tuberculosis during dual theraphy with pegylated interferon and ribavirin for chronic hepatitis C","volume":"31","author":"Belkahla","year":"2010","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.eimc.2011.03.009_bib0050","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.4049\/jimmunol.169.11.6343","article-title":"In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL\/6 mice","volume":"169","author":"Turner","year":"2002","journal-title":"J Immunol"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X11001297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X11001297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T17:05:40Z","timestamp":1686330340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X11001297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0213005X11001297"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2011.03.009","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}